Sanjeev Luther - 01 Jan 2024 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
President and CEO, Director
Signature
/s/ Sanjeev Luther
Issuer symbol
ERNA
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
4
Filing time
03 Jan 2024, 17:02:56 UTC
Next filing
10 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +1,685,218 $0.000000 1,685,218 01 Jan 2024 Common Stock, par value $0.005 per share 1,685,218 $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continued service, 25% of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 36 substantially equal monthly installments thereafter.